Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Methodological and statistical issues related to analysis of survival - Authors' reply.

Trickey A, May MT, Sterne JA.

Lancet HIV. 2017 Aug;4(8):e330. doi: 10.1016/S2352-3018(17)30136-4. No abstract available.

PMID:
28750743
2.

Methodological and statistical issues related to analysis of survival.

Alizadeh A, Morasae EK, Almasi-Hashiani A.

Lancet HIV. 2017 Aug;4(8):e330. doi: 10.1016/S2352-3018(17)30134-0. No abstract available.

PMID:
28750744
3.

The HIV response and global health - Authors' reply.

Bekker LG, Beyrer C, Isbell M.

Lancet. 2019 Apr 27;393(10182):1697. doi: 10.1016/S0140-6736(19)30347-2. No abstract available.

PMID:
31034376
4.

Authors' Reply: Evidence-Based Programming of HIV Care and Support: Is the Psychosocial "Optional"?

Kaplan JE, Bateganya MH, Hamm TE, Langley C.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e178-9. doi: 10.1097/QAI.0000000000000840. No abstract available.

PMID:
26569180
5.

GBD 2015 and HIV estimates from the Optima model - Authors' reply.

Wang H, Murray CJL.

Lancet HIV. 2016 Dec;3(12):e558-e559. doi: 10.1016/S2352-3018(16)30193-X. No abstract available.

PMID:
27884373
6.

Abstinence in HIV prevention: science and sophistry - Authors' reply.

Buse K, Hawkes S, Hildebrand M.

Lancet Glob Health. 2017 Jan;5(1):e31. doi: 10.1016/S2214-109X(16)30294-7. No abstract available.

7.

A unified hypothesis for three cardinal features of HIV immunology: authors' reply.

Dalgleish AG, Habeshaw J, Manca F.

J Acquir Immune Defic Syndr. 1991;4(11):1165. No abstract available.

PMID:
1801824
8.

Authors' reply: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator.

Pharris A, Quinten C, Noori T, Amato-Gauci AJ, van Sighem A.

Euro Surveill. 2016 Dec 15;21(50). pii: 30428. doi: 10.2807/1560-7917.ES.2016.21.50.30428. No abstract available.

9.

Letter: is HIV infection an important factor for liver fibrosis? Authors' reply.

Lui G, Wong VW, Lee N.

Aliment Pharmacol Ther. 2016 Nov;44(9):1002-1003. doi: 10.1111/apt.13792. No abstract available.

10.

Authors' Reply: Nutritional Support to HIV Patients Starting ART.

Tang AM, Quick T, Chung M, Wanke C.

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):e69-70. doi: 10.1097/QAI.0000000000000767. No abstract available.

PMID:
26218413
11.

Language used to convey HIV infection risk is important - Authors' reply.

Lundgren J, Phillips A.

Lancet HIV. 2018 Jun;5(6):e272. doi: 10.1016/S2352-3018(18)30105-X. No abstract available.

PMID:
29893240
12.

Introducing optimism to models of resource allocation to reduce HIV incidence - Authors' reply.

McGillen JB, Anderson SJ, Hallett TB.

Lancet HIV. 2017 Jan;4(1):e12. doi: 10.1016/S2352-3018(16)30228-4. No abstract available.

PMID:
28007345
13.

Wild-type HIV infection despite PrEP: a lot to learn from a case report - Authors' reply.

Hoornenborg E, Prins M, Prins JM, de Bree GJ.

Lancet HIV. 2018 Jan;5(1):e10-e11. doi: 10.1016/S2352-3018(17)30214-X. No abstract available.

PMID:
29290224
14.

HIV treatment-as-prevention research: authors' reply.

Bärnighausen T, Eyal N, Wikler D.

PLoS Med. 2015 Mar 10;12(3):e1001799. doi: 10.1371/journal.pmed.1001799. eCollection 2015 Mar.

15.

Maximising the effect of combination HIV prevention in Kenya--Authors' reply.

Anderson SJ, Harper M, Kilonzo N, Hallett TB.

Lancet. 2014 Oct 18;384(9952):1426-7. doi: 10.1016/S0140-6736(14)61860-2. Epub 2014 Oct 17. No abstract available. Erratum in: Lancet. 2014 Nov 1;384(9954):1576.

PMID:
25390323
16.
17.

Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.

Lombard C, Cousens S, Tylleskär T, Van de Perre P, Nagot N.

Lancet. 2016 May 21;387(10033):2091. doi: 10.1016/S0140-6736(16)30540-2. No abstract available.

PMID:
27301822
18.

Prioritisation of subgroups for immediate antiretroviral therapy - Authors' reply.

Molina JM, Grund B.

Lancet HIV. 2018 May;5(5):e206. doi: 10.1016/S2352-3018(18)30060-2. Epub 2018 May 1. No abstract available.

PMID:
29739694
19.

Light and shade behind the opt-out system for the HIV screening - Authors' reply.

Leber W, Anderson J, Figueroa J, Griffiths C; RHIVA2 team.

Lancet HIV. 2015 Aug;2(8):e317-8. doi: 10.1016/S2352-3018(15)00138-1. Epub 2015 Jul 29. No abstract available.

PMID:
26423373
20.

Editorial: NAFLD in HIV infection--call for action. Authors' reply.

Vodkin I, Loomba R.

Aliment Pharmacol Ther. 2015 Mar;41(6):591. doi: 10.1111/apt.13087. No abstract available.

Supplemental Content

Support Center